|
Volumn 514, Issue 7520, 2014, Pages 41-43
|
Medical research: Ebola therapy protects severely ill monkeys
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
AVI 6002;
MONOCLONAL ANTIBODY;
UNCLASSIFIED DRUG;
VESICULOVIRUS VACCINE;
VIRUS VACCINE;
VIRUS ANTIBODY;
ANTIBODY;
DISEASE INCIDENCE;
DISEASE SPREAD;
DISEASE TREATMENT;
MEDICINE;
RNA;
VIRAL DISEASE;
COMPASSIONATE USE;
DISEASE COURSE;
EBOLA HEMORRHAGIC FEVER;
EBOLA VIRUS;
FILOVIRUS;
HAPLORHINI;
HUMAN;
MARBURG VIRUS;
MICROBIAL DIVERSITY;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
VIRUS LOAD;
VIRUS STRAIN;
ANIMAL;
FEMALE;
MALE;
NOTE;
PASSIVE IMMUNIZATION;
WEST AFRICA;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, VIRAL;
FEMALE;
HEMORRHAGIC FEVER, EBOLA;
IMMUNIZATION, PASSIVE;
MALE;
|
EID: 84908028762
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/nature13746 Document Type: Short Survey |
Times cited : (14)
|
References (18)
|